Evidence map›Paper›PMID 25329159›Full record

ArticlePloS one2014

Supplementation with N-3 long-chain polyunsaturated fatty acids or olive oil in men and women with renal disease induces differential changes in the DNA methylation of FADS2 and ELOVL5 in peripheral blood mononuclear cells.

Samuel P Hoile, Rebecca Clarke-Harris, Rae-Chi Huang, Philip C Calder, Trevor A Mori, Lawrence J Beilin, Karen A Lillycrop, Graham C Burdge

Open access · goldAbstract readControlled Clinical Trial
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 3 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 3 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Antioxidants for adults with chronic kidney disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Samuel P HoileAcademic Unit of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Rebecca Clarke-HarrisAcademic Unit of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Rae-Chi HuangTelethon Kids Institute, Perth, Australia.
Philip C CalderAcademic Unit of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, United Kingdom.
Trevor A MoriSchool of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth, Australia.
Lawrence J BeilinSchool of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth, Australia.
Karen A LillycropCentre for Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, United Kingdom.
Graham C BurdgeAcademic Unit of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
University of Southampton · GBRoyal Perth Hospital · AUThe Kids Research Institute Australia · AUUniversity of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies in animal models and in cultured cells have shown that fatty acids can induce alterations in the DNA methylation of specific genes. There have been no studies of the effects of fatty acid supplementation on the epigenetic regulation of genes in adult humans. METHODS AND

resultsWe investigated the effect of supplementing renal patients with 4 g daily of either n-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) or olive oil (OO) for 8 weeks on the methylation status of individual CpG loci in the 5' regulatory region of genes involved in PUFA biosynthesis in peripheral blood mononuclear cells from men and women (aged 53 to 63 years). OO and n-3 LCPUFA each altered (>10% difference in methylation) 2/22 fatty acid desaturase (FADS)-2 CpGs, while n-3 LCPUFA, but not OO, altered (>10%) 1/12 ELOVL5 CpGs in men. OO altered (>6%) 8/22 FADS2 CpGs and (>3%) 3/12 elongase (ELOVL)-5 CpGs, while n-3 LCPUFA altered (>5%) 3/22 FADS2 CpGs and 2/12 (>3%) ELOVL5 CpGs in women. FADS1 or ELOVL2 methylation was unchanged. The n-3 PUFA supplementation findings were replicated in blood DNA from healthy adults (aged 23 to 30 years). The methylation status of the altered CpGs in FADS2 and ELOVL5 was associated negatively with the level of their transcripts.

conclusionsThese findings show that modest fatty acid supplementation can induce altered methylation of specific CpG loci in adult humans, contingent on the nature of the supplement and on sex. This has implications for understanding the effect of fatty acids on PUFA metabolism and cell function.

Indexed as

Dietary SupplementsDNA MethylationAcetyltransferasesAdultBase SequenceDelta-5 Fatty Acid DesaturaseFatty Acid DesaturasesFatty Acid ElongasesFatty Acids, Omega-3FemaleHumansLeukocytes, MononuclearMaleMiddle AgedMolecular Sequence DataOlive OilAcetyltransferasesDelta-5 Fatty Acid DesaturaseELOVL2 protein, humanELOVL5 protein, humanFADS1 protein, humanFADS2 protein, humanFatty Acid DesaturasesFatty Acid ElongasesFatty Acids, Omega-3Olive OilPlant Oils

Identifiers

PMID25329159
PMCPMC4201459
OpenAlexW1976756316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.